Expanded Testing to Detect Fentanyl and Fentanyl Analogues in Clinical Settings

Thursday, November 2, 2017 Clinical Trials News
Email Print This Page Comment bookmark
Font : A-A+

LOS ANGELES, Nov. 1, 2017 /PRNewswire/ -- Pacific Toxicology Laboratories responds to the dramatic increase in opioid overdose

deaths by developing expanded testing to detect fentanyl and fentanyl analogues in clinical settings.

Fentanyl and fentanyl analogues have been linked to the overdose deaths of over 20,000 men, women and children in the

United States in 2016. This reflects a greater than 500% increase over the previous three years. A FDA study reports that 82% of fentanyl overdose deaths involve illegally manufactured fentanyl and fentanyl analogues, compared with 4% originating from legal prescriptions. Data for the latter half of 2016 reveals that 70% of opioid overdose deaths resulted from fentanyl and fentanyl analogues. Illegally-manufactured fentanyl and fentanyl analogues are being used to strengthen the potency of heroin and counterfeit Oxycodone, Hydrocodone and other prescription opioid pain-management medications. "There are few these days that don't have family or friends who have been impacted by the Opioid Crisis. Our primary objective with the testing expansion is to give tools to treating medical providers to reduce the mortality rate," said Jeff Lanzolatta Pacific Toxicology Laboratories' CEO.

Except for the post-mortem analyses, there is little data on the use and abuse of fentanyl analogues because these substances have not heretofore been included in addiction treatment drug screening. Pacific Toxicology Laboratories now routinely screens and quantitates the presence of the following fentanyl analogues in urine samples:  Butyryl Fentanyl, N-Phenyl –1– 4 - Piperidianamine, Furanyl Fentanyl, Ocfentanil, Acetyl Fentanyl, Alfentanil, Remifentanil, Sufentanil, Valeryl Fentanyl, Para-Fluorofentanyl, (+/-)CIS- 3- Methyl Fentanyl, Carfentanil, and Nor Carfentanil.

Established in 1984, Pacific Toxicology Laboratories is an independent SAMHSA (Substance Abuse Mental Health Services Administration) certified and CLIA licensed laboratory. Pacific Toxicology Laboratories offers comprehensive testing services for substance abuse and mental health treatment centers.

If you would be interested in learning more contact Donald Simpson, M.D. or Jeff Lanzolatta at 818-678-4459 or go to http://www.pactox.com and click on latest news.

View original content:http://www.prnewswire.com/news-releases/expanded-testing-to-detect-fentanyl-and-fentanyl-analogues-in-clinical-settings-300548043.html

SOURCE Pacific Toxicology Laboratories



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store